Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretastatin A-4 (CA4). Our previous studies with benzocycloalkenyl and heteroaromatic ring systems yielded promising inhibitors with dihydronaphthalene and benzosuberene analogues featuring phenolic (KGP03 and KGP18) and aniline (KGP05 and KGP156) congeners emerging as lead agents. These molecules demonstrated dual mechanism of action, functioning both as potent vascular disrupting agents (VDAs) and as highly cytotoxic anticancer agents. A further series of analogues was designed to extend functional group diversity and investigate regioisomeric tolerance. Ten new molecules were effective inhibitors of tubulin polymerization (IC50 < 5 μM) with seven of these exhibiting highly potent activity comparable to CA4, KGP18, and KGP03. For one of the most effective agents, dose-dependent vascular shutdown was demonstrated using dynamic bioluminescence imaging in a human prostate tumor xenograft growing in a rat.

• Publication year

  2019

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2019-05-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.9b00551PMID 31059248PMCID PMC6925959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

  2018cited by this paper
• Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas

  2016cited by this paper
• Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.

  2016cited by this paper
• Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer

  2016cited by this paper
• Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery

  2016cited by this paper
• Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments.

  2015cited by this paper
• Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents.

  2015cited by this paper
• Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.

  2015cited by this paper
• GluN2B‐Selective N‐Methyl‐d‐aspartate (NMDA) Receptor Antagonists Derived from 3‐Benzazepines: Synthesis and Pharmacological Evaluation of Benzo[7]annulen‐7‐amines

  2014cited by this paper
• Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.

  2013cited by this paper
• Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).

  2013cited by this paper
• Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy

  2013cited by this paper
• New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluation.

  2013cited by this paper
• Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs.

  2013cited by this paper
• Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.

  2013cited by this paper
• An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity.

  2012cited by this paper
• Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts

  2012cited by this paper
• Synthesis of 3-methoxy-9-(3,4,5-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol, a potent antineoplastic benzosuberene derivative for anti-cancer chemotherapy

  2012cited by this paper
• Conformationally Restricted Naphthalene Derivatives Type isoCombretastatin A-4 and isoErianin Analogues: Synthesis, Cytotoxicity and Antitubulin Activity.

  2012cited by this paper
• Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity.

  2012cited by this paper
• An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.

  2011cited by this paper
• A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.

  2011cited by this paper
• Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

  2011cited by this paper
• In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome.

  2011cited by this paper
• Synthesis and discovery of water-soluble microtubule targeting agents that bind to the colchicine site on tubulin and circumvent Pgp mediated resistance.

  2010cited by this paper
• Development of Vascular Disrupting Agents

  2010cited by this paper
• Vascular Disruptive Agents for the Treatment of Cancer

  2010cited by this paper
• Vascular targeting therapy: potential benefit depends on tumor and host related effects.

  2010cited by this paper
• Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P.

  2009cited by this paper
• Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents.

  2009cited by this paper
• Microtubule-destabilizing agents: structural and mechanistic insights from the interaction of colchicine and vinblastine with tubulin.

  2009cited by this paper
• Recent development and SAR analysis of colchicine binding site inhibitors.

  2009cited by this paper
• Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.

  2008cited by this paper
• Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI

  2008cited by this paper
• Colchicine site inhibitors of microtubule integrity as vascular disrupting agents

  2008cited by this paper
• Synthesis and evaluation of the bioactivity of simplified analogs of the seco-pseudopterosins; progress toward determining a pharmacophore

  2008cited by this paper
• Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.

  2008cited by this paper
• Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines

  2008cited by this paper
• Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin

  2007cited by this paper
• Tumour targeting by microtubule-depolymerising vascular disrupting agents

  2007cited by this paper
• Characterizing the tumor response to treatment with combretastatin A4 phosphate.

  2007cited by this paper
• Chemoselective hydrogenation method catalyzed by Pd/C using diphenylsulfide as a reasonable catalyst poison

  2006cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper
• Tumor Vasculature: a Target for Anticancer Therapies

  2006cited by this paper
• Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.

  2006cited by this paper
• Vascular-Targeted Therapies in Oncology: Siemann/Vascular-Targeted Therapies in Oncology

  2006cited by this paper
• Molecular Recognition of the Colchicine Binding Site as a Design Paradigm for the Discovery and Development of Vascular Disrupting Agents

  2006cited by this paper
• A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.

  2005cited by this paper
• Disrupting tumour blood vessels

  2005cited by this paper
• The discovery and development of the combretastatins

  2005cited by this paper
• Tumor physiologic response to combretastatin A4 phosphate assessed by MRI.

  2005cited by this paper
• Differentiation and definition of vascular-targeted therapies.

  2005cited by this paper
• BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo

  2004cited by this paper
• Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging.

  2003cited by this paper
• Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.

  2003cited by this paper
• Functionalized stilbene derivatives as improved vascular targeting agents

  2002cited by this paper
• Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.

  2001cited by this paper
• Preparation of New Anti-Tubulin Ligands Through a Dual-Mode, Addition—Elimination Reaction to a Bromo-Substituted α,β-Unsaturated Sulfoxide.

  2001cited by this paper
• Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted alpha, beta-unsaturated sulfoxide.

  2000cited by this paper
• Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug.

  2000cited by this paper
• Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted α,β-unsaturated sulfoxide

  2000cited by this paper
• A new anti-tubulin agent containing the benzo[b]thiophene ring system.

  1999cited by this paper
• Antineoplastic agents. 379. Synthesis of phenstatin phosphate.

  1998cited by this paper
• Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

  1997cited by this paper
• Antimitotic natural products and their interactions with tubulin

  1996cited by this paper
• Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

  1995cited by this paper
• The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

  1995cited by this paper
• Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.

  1993cited by this paper
• Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.

  1993cited by this paper
• Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

  1993cited by this paper
• Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

  1991cited by this paper
• Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4

  1989cited by this paper
• Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.

  1987cited by this paper
• Electrochemical switching in anthraquinone-substituted carbon-pivot lariat ethers and podands: chain length effects in geometric and electronic cooperativity.

  1986cited by this paper
• Endothelial cell proliferation as a novel approach to targeting tumour therapy.

  1982cited by this paper
• Stabilization of the colchicine-binding activity of tubulin by organic acids.

  1981cited by this paper
• Alkaline phosphatase expression in human cell lines derived from various malignancies

  1981cited by this paper
• An improved catalytic OsO4 oxidation of olefins to cis-1,2-glycols using tertiary amine oxides as the oxidant

  1976cited by this paper
• Phosphorus pentoxide-methanesulfonic acid. Convenient alternative to polyphosphoric acid

  1973cited by this paper
• The Preparation of Methylcopper and some Observations on the Decomposition of Organocopper Compounds

  1952cited by this paper
• Studies in tissue metabolism: The action of colchicine and B. typhosus extract.

  1937cited by this paper
• Oxydation ungesättigter Verbindungen mittels organischer Superoxyde

  1909cited by this paper
• Ueber die Ersetzung der Amidgruppe durch Chlor in den aromatischen Substanzen

  1884cited by this paper
• Ueber die Ersetzung der Amid‐gruppe durch Chlor, Brom und Cyan in den aromatischen Substanzen

  1884cited by this paper

• Pd-Catalyzed Tandem Approach for 1,2,3-Triazolo-azepine Fused Benzosuberenes and 1,2,3-Triazolobenzazepines Synthesis.

  2025cites this paper
• Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity.

  2025cites this paper
• Targeting tumor-associated hypoxia with bioreductively activatable prodrug conjugates derived from dihydronaphthalene, benzosuberene, and indole-based inhibitors of tubulin polymerization

  2025cites this paper
• Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin Polymerization.

  2025cites this paper
• Photocatalytic Phosphine-Mediated Deoxygenative [3 + 2] Cycloaddition of α,β-Unsaturated Carbonyls and Alkenes.

  2025cites this paper
• Application of Chlorosulfonyl Isocyanate (CSI) in the Synthesis of Fused Tetracyclic Ketone Ring Systems.

  2024cites this paper
• Drug-Linker Constructs Bearing Unique Dual-Mechanism Tubulin Binding Payloads Tethered through Cleavable and Non-Cleavable Linkers.

  2024cites this paper
• Aluminum-Catalyzed Intramolecular Vinylation of Arenes by Vinyl Cations.

  2024cites this paper
• Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues.

  2023cites this paper
• Construction of Unique Spiro[dibenzo[a,f]azulene-6,2'-indenes] via Unprecedented Annulation of ortho-C-H Bond of Benzylidene Group.

  2023cites this paper
• Concise route to stereoselective chlorobenzene-based spiropyrrolidine oxindoles for pursuit as antitubercular agents

  2023cites this paper
• Design, Synthesis and Biological Evaluation of Prodrugs of 666-15 as Inhibitors of CREB-Mediated Gene Transcription.

  2022cites this paper
• Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

  2022cites this paper
• Progress of tubulin polymerization activity detection methods.

  2021cites this paper
• Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production.

  2021cites this paper
• Ni(ii), Cu(ii) and Zn(ii) complexes with the 1-trifluoroethoxyl-2,9,10-trimethoxy-7-oxoaporphine ligand simultaneously target microtubules and mitochondria for cancer therapy

  2021cites this paper
• Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors

  2021cites this paper
• Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers

  2021influential citation
• Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.

  2020cites this paper
• Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review

  2020cites this paper
• FAM172A suppresses polymerization of tubulin and development of HCC (Hepatocellular Carcinoma)

  2020cites this paper
• Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer

  2020cites this paper
• Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study.

  2020cites this paper
• In(OTf)3-catalyzed intramolecular hydroarylation of α-phenylallyl β-ketosulfones – synthesis of sulfonyl 1-benzosuberones and 1-tetralones

  2020cites this paper
• Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity

  2019cites this paper